Hindalco announced that the company’s wholly-owned subsidiary Novelis Inc. has completed the acquisition of US-based rolled products major, Aleris Corporation. Post this development, the stock of the company gained by nearly five per cent.

The market opened in the green on April 15, 2020, overall volumes in futures & options currently stand at 1.18 crore contracts with a turnover of Rs. 6,27,016.11 crore.

The company has secured the orders to build regional rapid transit system (RRTS) infrastructure from National Capital Region Transport Corporation (NCRTC) in Uttar Pradesh.

Jindal Steel & Power Limited (JSPL), the only private-sector company to manufacture head-hardened rails, has bagged 2,308-tonne supply order from Rail Vikas Nigam Limited (RVNL) for the development of Kolkata Metro Corporation.

During FY20, the company sustained its strong sales momentum across various brands, enhanced by the new project launches of 4th Avenue SunteckCity, Oshiwara District Centre (ODC), Goregaon (W) and Sunteck MaxXWorld, Naigaon. A significant progress in the construction work across projects along with strong pre-sales has led to a major ramp up in collections.

Lupin Limited has received an establishment inspection report (EIR) after closure of USFDA inspection of its Mandideep Unit II facility, classifying the inspection as voluntary action indicated.

ESG dedicated funds have delivered sustainable results in the last few years. So, should they form a part of your portfolio?

The level of 8,900 holds the key and at higher side, the level of 9,132 is likely to act as an immediate hurdle. Holding above this level, could lead to the further round of upmove towards the level of 9,350-9,400 in the near term. Stocks in news: Motherson Sumi, Dr Reddy’s Laboratories, Biocon, Hindalco Industries, Maruti Suzuki, Hero Motocorp.

On Wednesday morning, SGX Nifty is trading above 9,200-mark, indicating a gap-up start for the index; however, we feel the upmove may be restricted as the zone of 9,350-9,400 is a big hurdle to cross. On the earnings front, Wipro is slated to announce its Q4 numbers today.

On Tuesday, Dr Reddy’s Laboratories Ltd along with its subsidiaries announced the launch of an authorised generic version of NitroDur (nitroglycerin) Transdermal Infusion System in the US market. NitroDur is a trademark of USpharma Ltd.